Home
About
Overview
Sharing Data
ORCID
Help
History (33)
A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis.
Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.
Protection from primary sclerosing cholangitis: smoke trails of just coattails?
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
The role of biologics in ulcerative colitis.
See All 33 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The role of biologics in ulcerative colitis.
The role of biologics in ulcerative colitis. Dig Dis. 2010; 28(3):497-500.
View in:
PubMed
subject areas
Biological Products
Clinical Trials as Topic
Colitis, Ulcerative
Humans
Tumor Necrosis Factor-alpha
authors with profiles
Stephen B. Hanauer